In fight against cancer, it's boom times for radiopharmaceuticals

There are currently around 75 radiopharmaceutical startups in the U.S., several of which have raised sizable financing rounds this year.

November 10, 2023 Check out STAT+

Sponsored By

Mike Reddy for STAT STAT+ | In the fight against cancer, it's boom times for radiopharmaceuticals Investors and executives are optimistic these investments will pay off not just for venture capitalists, but for cancer patients. By Allison DeAngelis Why do some CAR-T cancer patients have severe complications? Data points to latent virus Manufacturing of CAR-T therapy can reactivate herpes, researchers find, but stress that the treatment is still essential. By Angus Chen HPV vaccines are so effective that new screening policies may be in order, suggests study A large new Finnish study found that a successful vaccination effort significantly depleted high-cancer-risk HPV types. By Annalisa Merelli

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Cancer Briefing? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser